CRF Health announced a significant investment of funds managed and advised by Vitruvian Partners, subject only to customary regulatory approvals. The transaction establishes Vitruvian as majority shareholder of CRF Health, while previous majority investor Verdane Capital VII and other shareholders will exit the company.

The new ownership will enable the company to continue to invest in its people, processes and technology to build upon its premier position in a rapidly growing market.

CRF Health provides electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. The company improves trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance.

“The use of electronic Clinical Outcome Assessments, or eCOA, has clearly come of age. We expect growth across all aspects of the business as pharmaceutical sponsors recognize the quality gains in clinical trial data provided by the use of such technologies,” said Rachael Wyllie, CEO of CRF Health. “As we seek to continue to strengthen the services we offer our client base, the investment from Vitruvian allows us to accelerate our plans and further enhance our technology and service offerings in the space.”